Revenue: $690 million, exceeding guidance by $10 million. Adjusted EBITDA: $64 million. Gross Margin: 28.7%, slightly above guidance. Operating Cash Flow: $93 million. Debt Reduction: Reduced revolving credit balance by $60 million. Net Loss: $1 million. Adjusted Earnings Per Share: $0.45. Nurse and Allied Revenue: $413 million, down 20% year-over-year. Physician and Leadership Solutions Revenue: $174 million, down 8% year-over-year. Technology and Workforce Solutions Revenue: $102 million, down 9% year-over-year. Day Sales Outstanding: 55 days, 9 days lower than a year ago. Warning! GuruFocus has detected 6 Warning Signs with AMN. Release Date: May 08, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points AMN Healthcare Services Inc (NYSE:AMN) exceeded revenue and profit margin expectations for the first quarter, with revenue reaching $690 million, $10 million above the high end of guidance. The company reported $64 million in adjusted EBITDA and demonstrated strong cash flow and debt reduction, reducing its revolving credit balance by $60 million. AMN Healthcare Services Inc (NYSE:AMN) experienced significant growth in locum tenens bookings and mid-teens year-over-year demand growth in its Allied business. The company has successfully implemented new technologies, such as the AMN Passport app and AI tools, to enhance recruiter productivity and improve service delivery. AMN Healthcare Services Inc (NYSE:AMN) achieved five new MSP and vendor-neutral client wins, reflecting improvement in win rates and strong client retention rates. Negative Points First quarter revenue was down 16% from the prior year and down 6% sequentially, indicating a decline in overall business performance. The Nurse and Allied Solutions segment experienced a 20% year-over-year revenue decline, primarily due to lower volume and rates. Consolidated gross margin decreased by 270 basis points year-over-year, with a sequential decline of 110 basis points. The company faces intense competition in the language services market, with industry consolidation leading to increased price competition. Demand has not recovered to pre-pandemic levels in several businesses, including travel nurse, interim leadership, and search, impacting overall revenue growth. Q & A Highlights Q: Can you talk about the VMS and MSP wins, and whether they were competitive wins or new to using these services? A: Cary Grace, President and CEO, explained that the wins were part of a strategic effort to broaden market positioning beyond MSP-centric approaches. The wins were characterized as small to medium, with some significant names involved, and they were competitive wins. The company is seeing a healthy pipeline growth and a shift back towards MSP interest. Story Continues Q: What are the dynamics in the Language Services segment, and how do you expect margins to unfold? A: Cary Grace noted that Language Services continues to see healthy growth despite some consolidation in the industry, which has put pressure on margins. The business remains high-growth and high-margin, with AMN well-positioned due to its efficient and high-quality solutions. Brian Scott, CFO and COO, added that they are taking steps to stabilize margins through cost adjustments without impacting service quality. Q: Are travel nurse bill rates stabilizing, and do you see a point where they can start building again? A: Cary Grace confirmed that bill rates have stabilized since the back half of 2024, with a current premium spread of contingent cost to permanent labor at about 11%. The company expects some bill rates to increase as the need for clinicians becomes more immediate. Q: What is driving the growth in labor disruption revenue, and can it become a consistent revenue stream? A: Cary Grace attributed the growth to internal focus and improved operational capabilities, rather than an increase in underlying labor disruptions. The company has enhanced its technology and automation, allowing it to support clients effectively. While the pipeline is strong, the timing and magnitude of labor disruptions remain unpredictable. Q: How is the competitive landscape affecting AMN, especially with potential acquisitions in the industry? A: Cary Grace stated that competition remains intense, with ongoing rationalization and consolidation expected in the market. Despite this, AMN believes it is well-positioned due to its broad solutions, platforms, and team capabilities, which are reflected in client wins and improved fill rates. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. View Comments
AMN Healthcare Services Inc (AMN) Q1 2025 Earnings Call Highlights: Exceeding Revenue ...
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...